Schedule a Meeting
Download Brochure
Table of Content
February 2025
The global cell culture media market size is calculated at USD 6.9 billion in 2024, grew to USD 7.69 billion in 2025, and is projected to reach around USD 20.32 billion by 2034. The market is expanding at a CAGR of 11.45% between 2025 and 2034. The growing research and development activities, burgeoning biotech sector, and technological advancements drive the market.
Unlock Infinite Advantages: Subscribe to Annual Membership
Cell culture is a laboratory technique for growing cells from different sources in a controlled environment. Cell culture media is a solid or liquid medium that supports cell growth. Cells can be grown in cell culture media from various sources, including mammals, plants, insects, bacteria, yeast, viruses, etc. These cells require basic environmental conditions for optimum growth, such as controlled temperature, a substrate for cell attachment, a growth medium, and incubators. Cell culture media comprises several components such as amino acids, vitamins, carbohydrates, inorganic salts, serum, hormones, buffers, supplements, and antibiotics. All these components are essential for cell growth.
Several factors are responsible for positively contributing to the market. The rising incidences and prevalence of chronic disorders necessitate research and development activities. Cell cultures are widely used in cell biology, cancer research, drug discovery, regenerative medicine, etc. The growing demand for large-scale biopharmaceutical manufacturing also potentiates market growth. The increasing investments and favorable government support are other factors augmenting the market. The availability of a suitable regulatory framework leads to new product launches, encouraging the use of cell culture media.
Artificial intelligence (AI) and machine learning (ML) algorithms have been found to play a pivotal role in the cell culture technique. They can automate the entire process, enhancing efficiency and reproducibility. They can also aid in the precise composition of cell culture media. The selection of the media components depends on the type of experiments and the cells to be grown. AI and ML can design customized media compositions with appropriate quantities, reducing manual errors. Moreover, they can also help researchers optimize the media composition and facilitate the modulation of critical quality attributes. Research conducted by the University of Toronto proved that AI results in 2x faster media preparation, 2x less experimental work needed, more than 50% reduction in error, and enhanced accuracy.
Regenerative Medicines
The major growth factor of the cell culture media market is the growing demand for regenerative medicines. Regenerative medicines include cell therapy, tissue engineering, organoids, etc. Several researchers are developing novel regenerative medicines to treat severe chronic disorders. These regenerative medicines, such as cell therapies and tissues, act by repairing or replacing damaged cells or tissues in the body. They need to be isolated, manipulated, and grown in a cell culture media before injecting into a patient’s body. Cell culture media is not only required for research purposes but also essential for large-scale manufacturing of cell therapies. It provides essential conditions required for cell therapy growth. The increasing number of new product approvals necessitates the use of cell culture media, boosting the market.
Poor Reproducibility and Chances of Contamination
The market faces formidable challenges, including poor reproducibility and chances of cross-contamination. Researchers or manufacturers have less control over the media’s physiological response. The lack of knowledge to prepare the exact composition of the media can result in poor reproducibility. Additionally, there are high chances of cross-contamination as bacterial and fungal cells grow faster than the desired animal cells. All these factors restrict market growth.
Burgeoning Biotech Sector
The future of the cell culture media market is promising, driven by the burgeoning pharmaceutical and biotechnology sectors. The growing research and development activities lead to the development of novel drugs and biologicals. The increasing investments in research and manufacturing of biologicals using huge culture vessels or bioreactors promote the market. The rising number of pharmaceutical and biotech startups shows a positive impact on the biotech sector. Every year, thousands of biotech startups are launched globally. These startups are supported by venture capital funding, promoting advancements in the field. The UK life sciences companies raised £1.25 billion in venture financing, comprising 11% of the total venture capital investments in the UK in 2023. The increasing number of CDMOs and CMOs also contribute to the burgeoning biotech sector, allowing companies to focus on product marketing.
By type, the liquid media segment held a dominant presence in the cell culture media market in 2024. Liquid media refers to a cell culture medium for culturing microorganisms or cells in a liquid. It is highly preferable to solid media as it allows for faster growth and higher isolation rates. They are easy to transfer, and temperature control and monitoring are more favorable. Liquids can reduce manufacturing costs and shorten production turnaround timelines. The ability to reduce media preparation time and increase consistency among batches also boosts the segment’s growth.
By type, the semi-solid & solid media segment will gain a significant share of the market over the studied period. Solid or semi-solid media provides mechanical support to the cells for optimal growth. They help to maintain the cell density, allowing for cell-matrix anchoring and cell-cell interactions. Compared to liquid media, they are less prone to cross-contamination, and maintenance of sterility is easier. Solid and semi-solid media are used for the isolation of pure culture as mixed bacteria can be separated on the same medium. All these advantages are likely to increase their demand in the coming years.
By product, the serum-free media segment held the largest share of the cell culture media market in 2024. Serum-free media contains essential nutritional and hormonal components other than animal sera. These components include CHO, BHK, and Vero. There are several disadvantages of using serum such as high cost and problems with standardization. However, serum-free media can overcome several disadvantages, leading to increased consistency and productivity as well as easier purification and downstream processing. The growing demand for animal welfare considerations and the limited availability of animal sera augment the segment’s growth.
By product, the stem cell culture media segment is predicted to witness significant growth in the cell culture media market over the forecast period. The growing demand for stem cell therapy and new product launches promote the segment’s growth. Stem cells are currently in high demand owing to their diverse applications in treating numerous disorders. They require culture media for their proliferation, maintenance, differentiation, expansion, and downstream applications. RPMI-1640 is the most common stem cell culture media.
By application, the biopharmaceutical production segment led the global cell culture media market in 2024. The rising incidences of chronic disorders increase the demand for biopharmaceutical production. The production of antibiotics, enzymes, monoclonal antibodies, therapeutic hormone formulations, and RNA therapeutics necessitate the use of cell culture media. The growing demand for precise and patient-centered treatment fuels the segment’s growth. Technological advancements and increasing investments revolutionize biopharmaceutical production.
By application, the diagnostics segment is projected to show lucrative growth in the market in the coming years. Advancements in diagnostics and growing proteomics, genomics, and metabolomics research contribute to the segment’s growth. Cell culture media are used to detect biomarkers involved in disease progression. Favorable government initiatives for screening and early detection of chronic disorders also propel the segment’s growth.
By end-use, the pharmaceutical & biotechnology segment registered its dominance over the global cell culture media market in 2024. The segmental growth is attributed to suitable infrastructure and state-of-the-art research and development facilities. The presence of skilled professionals and the increasing number of patents support the segment’s growth. Pharmaceutical & biotechnology companies develop and release novel therapeutics, which helps them to stay competitive in the market.
By end-use, the hospitals & diagnostic laboratories segment is projected to expand significantly in the market over the studied years. Advanced healthcare infrastructure and the increasing number of hospitalizations drive the segment’s growth. Hospitals & diagnostic laboratories have specialized equipment to detect certain chronic disorders, necessitating the use of cell culture media. The rising number of hospitals and growing awareness for early disease detection and regular check-ups also potentiate the demand for cell cultures.
North America dominated the global cell culture media market in 2024. The presence of key players, technological advancements, and favorable regulatory frameworks drive the market. Key players such as Thermo Fisher Scientific, Cytiva Life Sciences, Sigma Aldrich, and STEMCELL Technologies held the major share of the market in North America. Favorable government support also contributes to the market. The U.S. is a global leader in the biopharmaceutical sector due to its large domestic market, IP protection, and supportive innovation clusters. The increasing number of new product launches, especially biologicals, also propel the market.
For instance,
Asia-Pacific is anticipated to grow at the fastest rate in the cell culture media market during the forecast period. The rising incidences of chronic disorders due to the increasing geriatric population and growing investments drive the market. Countries like India, China, and Japan are at the forefront of developing novel biopharmaceuticals and support the use of cell culture media. The burgeoning biotech sector and favorable government support boost the market. The availability of suitable manufacturing infrastructure allows foreign investors to set up their manufacturing facilities in Asia-Pacific countries. This is also aligned with the affordable cost of manufacturing and skilled professionals. The Chinese government’s “Made in China 2025” and 14th Five-Year Plan policies potentiate the demand for cell culture media.
Darren Verlenden, Head of Process Solutions Life Science business sector at Merck, commented on the expansion of its Lenexa facility for cell culture media (CCM) production, that it reflects the company’s commitment to meet the dynamic needs of their customers and deliver on growth plans. He also said that the expansion makes it the company’s largest dry powder CCM facility and CoE in North America, ensuring to meet current and future demand for CCM.
By Type
By Product
By Application
By End-Use
By Region
February 2025
January 2025
January 2025
December 2024
Annual Access, Limitless Research! Unlock all market research reports with our annual subscription. Stay on top of market trends and crucial insights year-round!
2500+
Client Queries in 20235000+
Insights Published60+
Consulting Projects Per Year40+
Analysts